[HTML][HTML] Age-dependent changes on fractalkine forms and their contribution to neurodegenerative diseases

J Eugenín, L Eugenín-von Bernhardi… - Frontiers in molecular …, 2023 - frontiersin.org
The chemokine fractalkine (FKN, CX3CL1), a member of the CX3C subfamily, contributes to
neuron–glia interaction and the regulation of microglial cell activation. Fractalkine is …

Fractalkine in the nervous system: neuroprotective or neurotoxic molecule?

C Lauro, M Catalano, F Trettel… - Annals of the New York …, 2015 - Wiley Online Library
Fractalkine (CX3CL1) is an intriguing chemokine that plays a central role in the nervous
system. The expression of CX3CL1 on neurons and of its receptor CX3CR1 on microglia …

[HTML][HTML] Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice

AN Winter, MS Subbarayan, B Grimmig… - Journal of …, 2020 - Springer
Abstract Background Fractalkine (CX3CL1; FKN) is a chemokine expressed by neurons that
mediates communication between neurons and microglia. By regulating microglial activity …

Fractalkine receptor deficiency is associated with early protection but late worsening of outcome following brain trauma in mice

ER Zanier, F Marchesi, F Ortolano, C Perego… - Journal of …, 2016 - liebertpub.com
An impaired ability to regulate microglia activation by fractalkine (CX3CL1) leads to
microglia chronic sub-activation. How this condition affects outcome after acute brain injury …

[HTML][HTML] Modulating neurotoxicity through CX3CL1/CX3CR1 signaling

C Limatola, RM Ransohoff - Frontiers in cellular neuroscience, 2014 - frontiersin.org
Since the initial cloning of fractalkine/CX3CL1, it was proposed that the only known member
of the CX3C or δ subfamily of chemotactic cytokines could play some significant role in the …

Effects of cx3cr1 and fractalkine chemokines in amyloid beta clearance and p-tau accumulation in Alzheimer, s disease (ad) rodent models: is fractalkine a systemic …

JJ Merino, V Muñetón-Gómez… - Current Alzheimer …, 2016 - ingentaconnect.com
Microglia and astrocytes are the major source of cytokines in Alzheimer, s disease (AD).
CX3CR1 is a delta chemokine receptor found in microglia and its neuronal ligand …

Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival

O Meucci, A Fatatis, AA Simen… - Proceedings of the …, 2000 - National Acad Sciences
Recent in vitro and in vivo studies have shown that the chemokine fractalkine is widely
expressed in the brain and localized principally to neurons. Central nervous system …

[HTML][HTML] CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models

S Lee, NH Varvel, ME Konerth, G Xu… - The American journal of …, 2010 - Elsevier
Microglia, the primary immune effector cells in the brain, continually monitor the tissue
parenchyma for pathological alterations and become activated in Alzheimer's disease. Loss …

Fractalkine: moving from chemotaxis to neuroprotection

D Bérangère Ré, S Przedborski - Nature neuroscience, 2006 - nature.com
Fractalkine: moving from chemotaxis to neuroprotection | Nature Neuroscience Skip to main
content Thank you for visiting nature.com. You are using a browser version with limited support …

[HTML][HTML] Fractalkine enhances oligodendrocyte regeneration and remyelination in a demyelination mouse model

MMA de Almeida, AES Watson, S Bibi, NL Dittmann… - Stem cell reports, 2023 - cell.com
Demyelinating disorders of the central nervous system (CNS) occur when myelin and
oligodendrocytes are damaged or lost. Remyelination and regeneration of oligodendrocytes …